These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 4471028)
1. Biochemical vs clinical physiognomy of neuroleptics, with special reference to their antimanic effect. Dresse A Acta Psychiatr Belg; 1974 Sep; 74(5):485-7. PubMed ID: 4471028 [No Abstract] [Full Text] [Related]
2. Pharmacological vs. clinical physiognomy of neuroleptics, with special reference to their sedative and antipsychotic effects. Nielsen IM Acta Psychiatr Belg; 1974 Sep; 74(5):473-84. PubMed ID: 4471027 [No Abstract] [Full Text] [Related]
3. [Recent data on the mode of action of neuroleptics]. Bartholini G Actual Pharmacol (Paris); 1978; 30():35-47. PubMed ID: 28640 [No Abstract] [Full Text] [Related]
4. Clinical classification of neuroleptics, with special reference to their antimanic, antiautistic, and ataraxic properties. Bobon J; Pinchard A; Collard J; Bobon DP Compr Psychiatry; 1972 Mar; 13(2):123-31. PubMed ID: 5010592 [No Abstract] [Full Text] [Related]
5. [The effect of neuroleptics on the behavioral and electrographic reactions evoked by stimulation of the cerebral limbic structures]. Allikmets LKh; Vediaev FP Zh Vyssh Nerv Deiat Im I P Pavlova; 1967; 17(4):659-68. PubMed ID: 5620920 [No Abstract] [Full Text] [Related]
6. Role of brain dopamine in the antipsychotic effect of neuroleptics. Evidence from studies of amphetamine-neuroleptic interaction. Randrup A Mod Probl Pharmacopsychiatry; 1970; 5():60-5. PubMed ID: 5527170 [No Abstract] [Full Text] [Related]
7. The Liege physiognomy of neuroleptics, with special reference to thioxanthenes. Bobon DP; Gottfries CG Acta Psychiatr Belg; 1974 Sep; 74(5):535-44. PubMed ID: 4471035 [No Abstract] [Full Text] [Related]
8. Ataraxic and antimanic effects of thioxanthenes. Meurice E Acta Psychiatr Belg; 1974 Sep; 74(5):516-9. PubMed ID: 4471031 [No Abstract] [Full Text] [Related]
9. Antagonism by neuroleptics of abnormal behavior induced by activation of brain dopamine receptors. Van Rossum JM Mod Probl Pharmacopsychiatry; 1970; 5():65-7. PubMed ID: 5527171 [No Abstract] [Full Text] [Related]
10. [Disturbances of catecholamine metabolism (with special reference to dopamine) in the Parkinsonian syndrome]. Tissot R Presse Med (1893); 1969 Apr; 77(17):617-8. PubMed ID: 5785080 [No Abstract] [Full Text] [Related]
11. [Pharmacology of the limbic system. Action of psychotropic drugs]. Psatta D Stud Cercet Neurol; 1969; 14(1):3-34. PubMed ID: 4901803 [No Abstract] [Full Text] [Related]
12. Clinical and pharmacological spectral maps of the neuroleptics. Lewi PJ Int Pharmacopsychiatry; 1976; 11(3):181-9. PubMed ID: 992957 [TBL] [Abstract][Full Text] [Related]
13. A new comparative physiognomy of neuroleptics: a collaborative clinical report. Bobon J; Bobon DP; Pinchard A; Collard J; Ban TA; De Buck R; Hippius H; Lambert PA; Vinar O Acta Psychiatr Belg; 1972 Sep; 72(5):542-54. PubMed ID: 4669429 [No Abstract] [Full Text] [Related]
14. [Does electroencephalogram finding become a predictor of lithium response in bipolar disorder?]. Ikeda A; Kato T Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Oct; 23(5):219-21. PubMed ID: 14653228 [TBL] [Abstract][Full Text] [Related]
15. Effect of phenothiazines on dopamine metabolism and biochemistry of Parkinson's disease. Barbeau A Agressologie; 1968; 9(2):195-200. PubMed ID: 5675486 [No Abstract] [Full Text] [Related]
16. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity. Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184 [TBL] [Abstract][Full Text] [Related]
18. [l-dopa treatment of Parkinson's syndrome and mechanism of action of neuroleptics]. Degkwitz R Med Klin; 1969 Aug; 64(33):1451-6. PubMed ID: 4896563 [No Abstract] [Full Text] [Related]